[go: up one dir, main page]

MX2010000098A - Derivados de guanina policiclicos y sus metodos de uso. - Google Patents

Derivados de guanina policiclicos y sus metodos de uso.

Info

Publication number
MX2010000098A
MX2010000098A MX2010000098A MX2010000098A MX2010000098A MX 2010000098 A MX2010000098 A MX 2010000098A MX 2010000098 A MX2010000098 A MX 2010000098A MX 2010000098 A MX2010000098 A MX 2010000098A MX 2010000098 A MX2010000098 A MX 2010000098A
Authority
MX
Mexico
Prior art keywords
guanine derivatives
polycyclic guanine
polycyclic
derivatives
compositions
Prior art date
Application number
MX2010000098A
Other languages
English (en)
Inventor
Deen Tulshian
Van-Duc Le
William B Geiss
Gregory S Martin
James C Haber Jr
Julius J Matasi
Michael F Czarniecki
Stephanie Nicole Cooke
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2010000098A publication Critical patent/MX2010000098A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invenci?n se refiere a derivados de guanina polic?clicos, composiciones que comprenden los derivados de guanina polic?clicos y los m?todos de uso de los derivados de guanina polic?clicos para tratar el dolor o una enfermedad inflamatoria.
MX2010000098A 2007-06-21 2008-06-18 Derivados de guanina policiclicos y sus metodos de uso. MX2010000098A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94545207P 2007-06-21 2007-06-21
PCT/US2008/007592 WO2009002423A2 (en) 2007-06-21 2008-06-18 Polycyclic guanine derivatives and use thereof

Publications (1)

Publication Number Publication Date
MX2010000098A true MX2010000098A (es) 2010-04-21

Family

ID=40186205

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010000098A MX2010000098A (es) 2007-06-21 2008-06-18 Derivados de guanina policiclicos y sus metodos de uso.

Country Status (17)

Country Link
US (1) US8349858B2 (es)
EP (1) EP2170896A2 (es)
JP (1) JP2010530427A (es)
KR (1) KR20100023040A (es)
AR (1) AR067060A1 (es)
AU (1) AU2008269177A1 (es)
BR (1) BRPI0812909A2 (es)
CA (1) CA2691194A1 (es)
CL (1) CL2008001835A1 (es)
CO (1) CO6251257A2 (es)
EC (1) ECSP099822A (es)
IL (1) IL202754A0 (es)
MX (1) MX2010000098A (es)
PE (1) PE20090418A1 (es)
RU (1) RU2010101611A (es)
TW (1) TW200911817A (es)
WO (1) WO2009002423A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2523561A4 (en) * 2009-12-22 2013-06-05 Merck Sharp & Dohme 7,8-DIHYDRO-1H-IMIDAZO [2,1-B] PURINE-4 (5H) -ONE DERIVATIVES AND METHOD OF USE
US8691832B2 (en) * 2010-12-06 2014-04-08 Merck Sharp & Dohme Corp. Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
WO2013010679A1 (en) 2011-07-15 2013-01-24 Novartis Ag Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
BR112014016048B8 (pt) * 2011-12-30 2022-10-11 Dow Agrosciences Llc Métodos para formação e uso de ésteres de pinacol do ácido 4-cloro-2-flúor-3-substituído-fenilborônico e de 2-(4-cloro-2-flúor-3-metoxifenil)-4,4,5,5-tetrametil1,3,2-dioxaborolano, e éster de pinacol do ácido 4cloro-2-flúor-3-substituído-fenilborônico
CA2897464C (en) * 2013-01-28 2021-05-18 Incozen Therapeutics Pvt. Ltd. Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide
ES2689526T3 (es) 2013-03-14 2018-11-14 Janssen Pharmaceutica Nv Moduladores de P2X7
JO3509B1 (ar) 2013-03-14 2020-07-05 Janssen Pharmaceutica Nv معدلات p2x7
WO2014152589A1 (en) 2013-03-14 2014-09-25 Janssen Pharmaceutica Nv P2x7 modulators
TWI599567B (zh) 2013-03-14 2017-09-21 健生藥品公司 Ｐ２ｘ７調節劑
WO2016039983A1 (en) 2014-09-12 2016-03-17 Janssen Pharmaceutica Nv P2x7 modulating n-acyl-triazolopyrazines
ES2714048T3 (es) 2014-09-12 2019-05-24 Janssen Pharmaceutica Nv Moduladores de P2X7
ES2905399T3 (es) 2015-04-24 2022-04-08 Shionogi & Co Derivados heterocíclicos de seis miembros y composición farmacéutica que los comprende
JP7038460B2 (ja) * 2016-10-17 2022-03-18 塩野義製薬株式会社 二環性含窒素複素環誘導体およびそれらを含有する医薬組成物
AU2019350624B2 (en) 2018-09-28 2025-07-24 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
CN113164458B (zh) 2018-09-28 2024-09-13 詹森药业有限公司 单酰基甘油脂肪酶调节剂
JP7697934B2 (ja) 2019-09-30 2025-06-24 ヤンセン ファーマシューティカ エヌ．ベー． 放射線標識されたｍｇｌ ｐｅｔリガンド
MX2022011902A (es) 2020-03-26 2023-01-04 Janssen Pharmaceutica Nv Moduladores de la monoacilglicerol lipasa.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0119372A1 (en) 1983-03-21 1984-09-26 Svecia Silkscreen Maskiner AB Conveying device using a number of rollers
IL98559A0 (en) * 1990-06-21 1992-07-15 Schering Corp Polycyclic guanine derivatives
IL108754A0 (en) * 1993-02-26 1994-06-24 Schering Corp 2-benzyl-polycyclic guanine derivatives and process for preparing them
AU2566595A (en) 1994-05-27 1995-12-21 Glaxo Group Limited P-2x receptors (purinoceptor family)
US5856129A (en) 1996-10-30 1999-01-05 Incyte Pharmaceuticals, Inc. DNA encoding a human purinoceptor
WO1999055901A2 (en) 1998-04-30 1999-11-04 Abbott Laboratories Screening assay for identifying human purinoreceptor ligands
EP1327150A1 (en) 2000-10-13 2003-07-16 Bristol-Myers Squibb Company Methods for detecting modulators of ion channels using thallium (i) sensitive assays
US20020182646A1 (en) 2001-04-30 2002-12-05 Ke Huazhu Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders
CA2457944C (en) * 2001-08-28 2009-09-29 Schering Corporation Polycyclic guanine phosphodiesterase v inhibitors
US20050238650A1 (en) 2002-04-17 2005-10-27 Genentech, Inc. Compositions and methods for the treatment of tumor of hematopoietic origin
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP2005509038A (ja) * 2001-11-09 2005-04-07 シェーリング　コーポレイション 多環式グアニン誘導体ホスホジエステラーゼｖ阻害剤
US7560243B2 (en) 2003-04-21 2009-07-14 Wisconsin Alumni Research Foundation White blood cell functional assay
GB0323147D0 (en) 2003-10-03 2003-11-05 Medical Res Council Improvements in or relating to concentration of intracellular agents
EP1885360A2 (en) 2005-05-31 2008-02-13 Duska Scientific Co Inhibition of neuronal damage
WO2007115192A2 (en) 2006-03-31 2007-10-11 Abbott Laboratories P2x7 antagonists to treat affective disorders

Also Published As

Publication number Publication date
JP2010530427A (ja) 2010-09-09
BRPI0812909A2 (pt) 2014-12-09
TW200911817A (en) 2009-03-16
US8349858B2 (en) 2013-01-08
WO2009002423A3 (en) 2009-04-23
CA2691194A1 (en) 2008-12-31
WO2009002423A2 (en) 2008-12-31
KR20100023040A (ko) 2010-03-03
CO6251257A2 (es) 2011-02-21
PE20090418A1 (es) 2009-04-18
AU2008269177A1 (en) 2008-12-31
ECSP099822A (es) 2010-01-29
US20110065738A1 (en) 2011-03-17
AR067060A1 (es) 2009-09-30
IL202754A0 (en) 2010-06-30
EP2170896A2 (en) 2010-04-07
RU2010101611A (ru) 2011-07-27
CL2008001835A1 (es) 2008-12-26

Similar Documents

Publication Publication Date Title
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
MX380755B (es) Derivados de piperidin-4-il azetidina como inhibidores de janus cinasa 1 (jak1).
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
CA2871471C (en) Dna-pk inhibitors
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
PH12012500620A1 (en) Compounds
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2009009429A (es) Analogos de ciclopamina lactama y metodos de uso de los mismos.
NO20092637L (no) Fremgangsmater for behandling
UA101493C2 (ru) Производные азетидина и циклобутана как ингибиторы jak
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
EA201170832A1 (ru) Пуриновые соединения
IN2012DN02471A (es)
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
MX2009009190A (es) Compuestos heterociclicos, composiciones que los comprenden y metodos que los emplean.
MX2011008645A (es) Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
EP2069346A4 (en) ACETAMIDE AND CARBOXAMIDE AZAADAMANTANE DERIVATIVES AND METHODS OF USE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal